IDiyas

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Yanggu Shi

USPTO Granted Patents = 26 

Average Co-Inventor Count = 4.5

ph-index = 12

Forward Citations = 380(Granted Patents)


Company Filing History:

goldMedal26 out of 676 
 
Human Genome Sciences, Inc.
 patents

Years Active: 2000-2012

Loading Chart...
26 patents (USPTO):Explore Patents
1. 8133734 - Kit comprising an antibody to interleukin 17 receptor-like protein (2012-03-13),
2. 7638603 - Antibodies against interleukin 17 receptor-like protein (2009-12-29),
3. 7459531 - 50 Human secreted proteins (2008-12-02),
4. 7381800 - Antibodies to HBIMF63 polypeptide (2008-06-03),
5. 7247442 - Antibodies to HHPEN62 polypeptide (2007-07-24),
6. 7169565 - Antibodies to HASAV70 polypeptide (2007-01-30),
7. 7053190 - Secreted protein HRGDF73 (2006-05-30),
8. 6953667 - Antibodies against human protein HUVDJ43 (2005-10-11),
9. 6936691 - Secreted protein HCE3C63 (2005-08-30),
10. 6878687 - Protein HMAAD57 (2005-04-12),
11. 6849719 - Antibody to an IL-17 receptor like protein (2005-02-01),
12. 6770466 - Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies (2004-08-03),
13. 6753164 - Nucleic acids encoding human serpin polypeptide HMCIS41 (2004-06-22),
14. 6743613 - Lysyl-oxidase HOHEC84 polynucleotides (2004-06-01),
15. 6635443 - Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein (2003-10-21),

Title: Innovations by Yanggu Shi: Contributions to Immunology

Introduction

Yanggu Shi, based in Gaithersburg, MD, is a notable inventor with an impressive portfolio of 26 patents. His work primarily revolves around advancements in immunology, particularly focusing on interleukin receptor proteins.

Latest Patents

Among his latest contributions is the "Kit comprising an antibody to interleukin 17 receptor-like protein." This invention relates to a novel IL17RLP protein from the interleukin-17 receptor family. The patent provides isolated nucleic acid molecules that encode the human IL17RLP protein. It also includes IL17RLP polypeptides, vectors, host cells, and recombinant methods for production. Furthermore, the invention outlines various screening methods for identifying agonists and antagonists of IL17RLP activity, as well as diagnostic and therapeutic methods for immune system-related disorders.

Another significant patent from Yanggu Shi is titled "Antibodies against interleukin 17 receptor-like protein." Similar to his previous work, this invention focuses on the IL17RLP protein and covers identical methodologies for diagnosis and treatment of immune system disorders.

Career Highlights

Yanggu Shi is currently employed at Human Genome Sciences, Inc., where he leverages his expertise in biotechnology and immunology. His contributions have significantly advanced the understanding and treatment of various immune-related conditions.

Collaborations

Throughout his career, Yanggu has collaborated with esteemed professionals in the field, including Steven M. Ruben and Craig A. Rosen. These partnerships have fostered innovation and contributed to the success of their collective research efforts.

Conclusion

Yanggu Shi's body of work exemplifies the importance of innovation in the field of immunology. His patents are instrumental in developing new diagnostics and therapies aimed at strengthening the human immune system. As he continues his work at Human Genome Sciences, Inc., the potential for future advancements remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…